ARXActive

Will Hadron's share of ARX third-party insurer premium fall below 33% by Q4 2026?

Resolves March 15, 2027(355d)

IG: 0.64

Current Prediction

48%

Likely No

Model Agreement94%

Predictions9 runs

Last UpdatedMarch 23, 2026

Why This Question Matters

Hadron concentration is the central counterparty risk, flagged by three lenses (Fugazi Filter, Gravy Gauge, Stress Scanner). Achieving below 33% would validate management's diversification roadmap and de-escalate funding fragility. Failure to diversify would confirm single-counterparty vulnerability in the platform model.

FUNDING_FRAGILITYREVENUE_DURABILITY

Prediction Distribution

0%25%50%75%100%

opus

sonnet

haiku

Range: 45% – 55%Aggregate: 48%

Individual Predictions(9 runs)

opusRun 1

55%

Management has provided a specific roadmap: Hadron 35-40% of FY2026 third-party DWP with target below 33% by Q4. The declining trajectory from 58% to 54% in one quarter, plus 4 new insurer partners including Lloyd's, supports diversification. The $1.8B under contract from non-Hadron sources is the strongest evidence.

$1.8B non-Hadron DWP under contract58% to 54% trajectory in one quarter4 new insurer partners including Lloyd's

opusRun 2

48%

The math requires non-Hadron third-party premium to grow much faster than Hadron. If FY2026 total third-party DWP is $2.1B and Hadron stays at roughly $680M, Hadron would be about 32%. But this requires the $300M in additional and conversion pipeline to materialize. Regulatory friction on new relationships is a real constraint.

$300M of non-Hadron DWP not yet flowingRegulatory friction on new relationshipsHadron growth could offset diversification

opusRun 3

52%

Management specifically guided to below 33% by Q4 2026 with detailed breakdowns. Setting such a specific public target creates accountability. The new Lloyd's facility and purpose-built Ozark Specialty demonstrate concrete diversification efforts.

Management set specific public targetLloyd's and Ozark are concrete diversification35-40% full-year converging to below 33% by Q4 is plausible

sonnetRun 1

45%

21 percentage points of concentration reduction in 4 quarters is aggressive. Regulatory timelines for rate and form approvals can add 6-12 months to new relationships. The $300M in uncertain pipeline represents real execution risk.

21pp reduction in 4 quarters is aggressiveRegulatory approval timelines 6-12 months$300M in uncertain pipeline

sonnetRun 2

50%

True coin-flip. Management has strong incentives to hit this target given analyst scrutiny. The $1.8B under contract provides a solid foundation, and 4 new partners demonstrate momentum. But insurance partner onboarding is inherently slow.

Management incentive to hit widely-watched target$1.8B contracted foundation is solidHadron growth could offset diversification

sonnetRun 3

47%

The market asks specifically about Q4 2026 snapshot, not FY2026 average. Concentration should decline progressively as new partners ramp. Management target aligns with resolution criteria, suggesting achievable but a stretch goal.

Q4 snapshot benefits from full-year rampManagement guidance aligns with resolution criteriaStretch goal rather than conservative estimate

haikuRun 1

50%

Management target matches question. $1.8B under contract supports achievability. But regulatory friction and conversion uncertainty make it a coin-flip.

Management target alignment$1.8B contracted non-Hadron DWPRegulatory friction risk

haikuRun 2

45%

Insurance partner onboarding is slow. While trajectory is positive, hitting exactly below 33% by Q4 requires precise execution. Slightly below 50%.

Slow insurance partner onboardingTiming precision requiredPositive trajectory but execution risk

haikuRun 3

48%

Near coin-flip. Management credibility on this specific target is being tested. The new partners are concrete but scaling takes time.

Management credibility at stakeConcrete new partners existScaling takes time

Resolution Criteria

Resolves YES if Accelerant's Q4 2026 10-Q or earnings filing discloses Hadron's share of third-party insurer premium below 33%. Resolves NO if Hadron share remains at or above 33%.

Resolution Source

ARX Q4 2026 10-Q filing or Q4 2026 earnings call disclosure

Source Trigger

Track third-party insurer premium concentration in quarterly filings. Target: below 33% by Q4 2026.

stress-scannerFUNDING_FRAGILITYHIGH

View ARX Analysis

Full multi-lens equity analysis